Natco Pharma Ltd - Share Price
NATCOPHARM
Natco Pharma LtdFinancials
Natco Pharma LtdNews & Updates
Volumes soar at Natco Pharma Ltd counter
May 22,2020 11:00 AM
Natco Pharma Ltd recorded volume of 4.04 lakh shares by 10:53 IST on BSE, a 41.46 times surge over two-week average daily volume o
Natco Pharma receives EIR for its Vizag facility May 20,2020
Natco Pharma gets EIR from USFDA for Visakhapatnam unit; shares end flat May 20,2020
Natco up 3% on donating Chloroquine tablets to cushion healthcare workers from Covid-19 May 19,2020
Natco Pharma donates Chloroquine Phosphate Tablets to support clinical trail by CROWN Collaborative May 19,2020
Natco Pharma receives its first sANDA approval filed from its new Vizag formulations facility Apr 28,2020
Meeting Type
Meeting Date
| Resolution Type | Description Of Resolution | IiAS Recommendation |
|---|
Peer Comparison
| Name | LTP | PE | Mar Cap | NP Qtr | Div. Yld | Sales Qtr | BV |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceuticals Industries Ltd | 494.85 | 37.00 | 118,767.08 | 1,155.85 | 0.81 | 2,750.41 | 101.68 |
| Dr Reddys Laboratories Ltd | 3,998.90 | 22.62 | 66,460.52 | 502.80 | 0.63 | 2,837.90 | 914.23 |
| Divis Laboratories Ltd | 2,421.15 | 50.59 | 64,263.31 | 360.73 | 0.66 | 1,390.49 | 266.77 |
| Cipla Ltd | 660.55 | 22.99 | 53,286.45 | 604.57 | 0.61 | 3,042.01 | 215.85 |
| Biocon Ltd | 393.65 | 150.82 | 47,238.00 | 102.20 | 0.00 | 482.40 | 62.80 |
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Natco Pharma LtdSummary & Reports
No Company Summary found
Registered Office
Natco House,Road No 2 Banjara Hills,Hyderabad, Telangana,500033
Tell. : +91-040-23547532
Website : http://www.natcopharma.co.in
Email : investors@natcopharma.co.in
Registrar Office
12-10-167, Bharath Nagar, Hyderbad - 500018 INDIA
Tell. : +91-040-23818475/76/2
Website : www.vccilindia.com
Email : info@vccilindia.com
Reports by natco-pharma-ltd
Latest Release by natco-pharma-ltd
Result Express
Natco Pharma Ltd's Q2FY19 consolidated net profit rises 115.17% yoy to Rs181.60cr : Misses Estimates
Jun 05, 2020 04:25 AM
The company’s consolidated revenue stood at Rs543.50cr, up 27.37% yoy and 0.91% qoq.
Shareholding Snapshot
Loading ...
| Mar - 2020 | |
|---|---|
| Promoter | - |
| Foreign | 0.00% |
| Indian | 48.93% |
| Total Promoter | 48.93% |
| Non Promoter | - |
| Institutions | 32.24% |
| Non-Institutions | 18.83% |
| Total Non-Promoter | 51.07% |
| Custodian | 0.00% |
| Total | 100% |
Corporate Action
Purpose
Dividend
Annc. Date
12 Feb 2020
Effective. Date
24 Feb 2020
Divi. Type
Interim 3
Divi.(%)
175
Divi. Amt.
3.5
The Board of Directors of the Company at their meeting held on 12/2/2020 have declared 3rd Interim D... More
Purpose
Board Meeting
Exp. Date
12 Feb 2020
Annc. Date
03 Feb 2020
NATCO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is sched... More
Purpose
Dividend
Annc. Date
12 Nov 2019
Effective. Date
21 Nov 2019
Divi. Type
Interim 2
Divi.(%)
50
Divi. Amt.
1
Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on ... More
